Main Navigation
Mercia
Ventures
Debt
Private equity
Contact us
About us
Investment strategies
Investor area
PLC
EIS
VCT
Contact us
Audience
|
Change
Ventures
Debt
Private equity
Contact us
About us
About us
Our history
Our vision and values
University partnerships
Team
Careers
Portfolio
Sustainability
Strategies
Our investment strategy
Our funds
Strategic assets
Property development finance
EIS & VCT
For shareholders
Share price
Board of directors
Financial reports & presentations
Regulatory news
Corporate governance
AIM Rule 26
Organisational structure
Annual Report
VCT
Northern Venture Trust
Northern 2 VCT
Northern 3 VCT
Insights & Research
Hub
Ventures
Debt
Private equity
Contact us
About us
Investment strategies
Investor area
PLC
EIS
VCT
Contact us
About us
About us
Our history
Our vision and values
University partnerships
Team
Careers
Portfolio
Sustainability
Strategies
Our investment strategy
Our funds
Strategic assets
Property development finance
EIS & VCT
For shareholders
Share price
Board of directors
Financial reports & presentations
Regulatory news
Corporate governance
AIM Rule 26
Organisational structure
Annual Report
VCT
Northern Venture Trust
Northern 2 VCT
Northern 3 VCT
Insights & Research
Hub
Pharma and Healthcare
Pharma and Healthcare
Direct Investments | 9th July, 2020
Mercia sells stake in biotech EIS portfolio business spun out from the University of Birmingham
News | 28th November, 2016
Lancashire-based medical supplier takes the lead in x-ray protection
Loading...
Loading...
Disclaimer
Which of these options best describes you?
Please wait...
Disclaimers
Which of these options best describes you?
Please wait...
Loading...
Loading...
Disclaimer
Which of these options best describes you?
Please wait...
Disclaimers
Which of these options best describes you?
Please wait...